Synaptogenix, Inc. (SNPX)
NASDAQ: SNPX · Real-Time Price · USD
2.651
+0.191 (7.76%)
Nov 20, 2024, 4:00 PM EST - Market closed
Synaptogenix Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 5.01 | 6.34 | 9.81 | 8.28 | 8.09 | 9.84 |
| Research & Development | 1.75 | 1.97 | 6.32 | 4.34 | 3.07 | 5.67 |
| Operating Expenses | 6.76 | 8.31 | 16.13 | 12.62 | 11.16 | 15.51 |
| Operating Income | -6.76 | -8.31 | -16.13 | -12.62 | -11.16 | -15.51 |
| Interest & Investment Income | 1.37 | 1.65 | 0.34 | 0.01 | 0.15 | 0.38 |
| Other Non Operating Income (Expenses) | -2.79 | 0.63 | 10.23 | - | -1.7 | - |
| Pretax Income | -8.22 | -6.04 | -5.57 | -12.61 | -12.7 | -15.13 |
| Net Income | -8.22 | -6.04 | -5.57 | -12.61 | -12.7 | -15.13 |
| Preferred Dividends & Other Adjustments | 0.91 | 7.74 | 0.12 | - | 2.43 | - |
| Net Income to Common | -9.13 | -13.78 | -5.69 | -12.61 | -15.13 | -15.13 |
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | 0 |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | 0 |
| Shares Change (YoY) | 240.32% | 66.71% | 39.36% | 298.79% | - | - |
| EPS (Basic) | -8.26 | -29.56 | -20.35 | -62.87 | -300.78 | -300.87 |
| EPS (Diluted) | -8.26 | -29.56 | -20.35 | -62.87 | -300.78 | -300.87 |
| Free Cash Flow | -4.78 | -5.18 | -11.22 | -8.71 | -8.11 | -11.89 |
| Free Cash Flow Per Share | -4.32 | -11.11 | -40.13 | -43.44 | -161.18 | -236.41 |
| EBITDA | -6.76 | -8.31 | -16.13 | -12.61 | -11.15 | -15.51 |
| D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 |
| EBIT | -6.76 | -8.31 | -16.13 | -12.62 | -11.16 | -15.51 |
Source: S&P Capital IQ. Standard template.
Financial Sources.